The anti-trypanosomal agent lonidamine inhibits Trypanosoma brucei hexokinase 1

Molecular and Biochemical Parasitology

Volumn 158, Issue 2, 2008, Pages 202-207

  Chambers, Jeremy W ^a   Fowler, Matthew L ^a   Morris, Meredith T ^a   Morris, James C ^a  

^a CLEMSON UNIVERSITY   (United States)

Author keywords

Hexokinase; Lonidamine; Trypanosoma brucei

Indexed keywords

HEXOKINASE; HEXOKINASE ISOENZYME; LONIDAMINE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD FLOW; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE SILENCING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; TRYPANOSOMA BRUCEI;

ANIMALS; CULTURE MEDIA; ENZYME INHIBITORS; GENE SILENCING; HEXOKINASE; INDAZOLES; RECOMBINANT PROTEINS; RNA INTERFERENCE; TRANSFECTION; TRYPANOCIDAL AGENTS; TRYPANOSOMA BRUCEI BRUCEI;

PROTOZOA; TRYPANOSOMA BRUCEI;

EID: 39049107429     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbiopara.2007.12.013     Document Type: Article

References (37)

1. Remme J.H., Blas E., Chitsulo L., et al. Strategic emphases for tropical diseases research: a TDR perspective. Trends Parasitol 18 (2002) 421-426
2. Pepin J., and Milord F. African trypanosomiasis and drug-induced encephalopathy: risk factors and pathogenesis. Trans R Soc Trop Med Hyg 85 (1991) 222-224
3. Willson M., Sanejouand Y.H., Perie J., Hannaert V., and Opperdoes F. Sequencing, modeling, and selective inhibition of Trypanosoma brucei hexokinase. Chem Biol 9 (2002) 839-847
4. Silvestrini B., Burberi S., Catanese B., et al. Antispermatogenic activity of 1-p-chlorobenzyl-1H-indazol-3-carboxylic acid (AF 1312/TS) in rats. I. Trials of single and short-term administrations with study of pharmacologic and toxicologic effects. Exp Mol Pathol 23 (1975) 288-307
5. Paggi M.G., Fanciulli M., Perrotti N., et al. The role of mitochondrial hexokinase in neoplastic phenotype and its sensitivity to lonidamine. Ann N Y Acad Sci 551 (1988) 358-360
6. Floridi A., and Lehninger A.L. Action of the antitumor and antispermatogenic agent lonidamine on electron transport in Ehrlich ascites tumor mitochondria. Arch Biochem Biophys 226 (1983) 73-83
7. Floridi A., Paggi M.G., Marcante M.L., et al. a selective inhibitor of aerobic glycolysis of murine tumor cells. J Natl Cancer Inst 66 (1981) 497-499
8. Floridi A., Paggi M.G., D'Atri S., et al. Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells. Cancer Res 41 (1981) 4661-4666
9. Costantini P., Jacotot E., Decaudin D., and Kroemer G. Mitochondrion as a novel target of anticancer chemotherapy. J Natl Cancer Inst 92 (2000) 1042-1053
10. Manganaro M., Luparini M.R., Ricciolini R., Calio F., Miccheli A., and Conti F. Trypanosoma lewisi: study of the activity of lonidamine in vitro and in vivo in rats. Cell Mol Biol 34 (1988) 517-528
11. Turrens J.F., and Cazzulo J.J. Inhibition of growth and respiration of Leishmania mexicana by the antitumor agent lonidamine. Comp Biochem Physiol C 88 (1987) 193-196
12. Turrens J.F. Inhibitory action of the antitumor agent lonidamine on mitochondrial respiration of Trypanosoma cruzi and T. brucei. Mol Biochem Parasitol 20 (1986) 237-241
13. Morris J.C., Wang Z., Drew M.E., Paul K.S., and Englund P.T. Inhibition of bloodstream form Trypanosoma brucei gene expression by RNA interference using the pZJM dual T7 vector. Mol Biochem Parasitol 117 (2001) 111-113
14. Morris J.C., Wang Z., Drew M.E., and Englund P.T. Glycolysis modulates trypanosome glycoprotein expression as revealed by an RNAi library. EMBO J 21 (2002) 4429-4438
15. Albert M.A., Haanstra J.R., Hannaert V., et al. Experimental and in silico analyses of glycolytic flux control in bloodstream form Trypanosoma brucei. J Biol Chem 280 (2005) 28306-28315
16. Morris M.T., DeBruin C., Yang Z., Chambers J.W., Smith K.S., and Morris J.C. Activity of a second Trypanosoma brucei hexokinase is controlled by an 18-amino-acid C-terminal tail. Eukaryot Cell 5 (2006) 2014-2023
17. Wirtz E., Leal S., Ochatt C., and Cross G.A. A tightly regulated inducible expression system for conditional gene knock-outs and dominant-negative genetics in Trypanosoma brucei. Mol Biochem Parasitol 99 (1999) 89-101
18. Wang Z., Morris J.C., Drew M.E., and Englund P.T. Inhibition of Trypanosoma brucei gene expression by RNA interference using an integratable vector with opposing T7 promoters. J Biol Chem 275 (2000) 40174-40179
19. Motyka S.A., Drew M.E., Yildirir G., and Englund P.T. Overexpression of a cytochrome b5 reductase-like protein causes kinetoplast DNA loss in Trypanosoma brucei. J Biol Chem 281 (2006) 18499-18506
20. Hudock M.P., Sanz-Rodriguez C.E., Song Y., et al. Inhibition of Trypanosoma cruzi hexokinase by bisphosphonates. J Med Chem 49 (2006) 215-223
21. Sanz-Rodriguez C.E., Concepcion J.L., Pekerar S., Oldfield E., and Urbina J.A. Bisphosphonates as inhibitors of Trypanosoma cruzi hexokinase: kinetic and metabolic studies. J Biol Chem 282 (2007) 12377-12387
22. Drew M.E., Morris J.C., Wang Z., et al. The adenosine analog tubercidin inhibits Glycolysis in Trypanosoma brucei as revealed by an RNA interference library. J Biol Chem 278 (2003) 46596-46600
23. Amadori D., Frassineti G.L., De Matteis A., et al. Modulating effect of lonidamine on response to doxorubicin in metastatic breast cancer patients: results from a multicenter prospective randomized trial. Breast Cancer Res Treat 49 (1998) 209-217
24. Magno L., Terraneo F., Bertoni F., et al. Double-blind randomized study of lonidamine and radiotherapy in head and neck cancer. Int J Radiat Oncol Biol Phys 29 (1994) 45-55
25. Racagni G.E., and Machado de Domenech E.E. Characterization of Trypanosoma cruzi hexokinase. Mol Biochem Parasitol 9 (1983) 181-188
26. Caceres A.J., Portillo R., Acosta H., et al. Molecular and biochemical characterization of hexokinase from Trypanosoma cruzi. Mol Biochem Parasitol 126 (2003) 251-262
27. Gong X., Burbridge S.M., Lewis A.C., Wong P.Y., and Linsdell P. Mechanism of lonidamine inhibition of the CFTR chloride channel. Br J Pharmacol 137 (2002) 928-936
28. Cross G.A., Klein R.A., and Linstead D.J. Utilization of amino acids by Trypanosoma brucei in culture: l-threonine as a precursor for acetate. Parasitology 71 (1975) 311-326
29. ter Kuile B.H. Adaptation of metabolic enzyme activities of Trypanosoma brucei promastigotes to growth rate and carbon regimen. J Bacteriol 179 (1997) 4699-4705
30. Bursell E., Billing K.J., Hargrove J.W., McCabe C.T., and Slack E. The supply of substrates to the flight muscle of tsetse flies. Trans R Soc Trop Med Hyg 67 (1973) 296
31. Balogun R.A. Studies on the amino acids of the tsetse fly, Glossina morsitans, maintained on in vitro and in vivo feeding systems. Comp Biochem Physiol A 49 (1974) 215-222
32. Lamour N., Riviere L., Coustou V., Coombs G.H., Barrett M.P., and Bringaud F. Proline metabolism in procyclic Trypanosoma brucei is down-regulated in the presence of glucose. J Biol Chem 280 (2005) 11902-11910
33. van Weelden S.W., van Hellemond J.J., Opperdoes F.R., and Tielens A.G. New functions for parts of the Krebs cycle in procyclic Trypanosoma brucei, a cycle not operating as a cycle. J Biol Chem 280 (2005) 12451-12460
34. Furuya T., Kessler P., Jardim A., Schnaufer A., Crudder C., and Parsons M. Glucose is toxic to glycosome-deficient trypanosomes. Proc Natl Acad Sci USA 99 (2002) 14177-14182
35. Guerra-Giraldez C., Quijada L., and Clayton C.E. Compartmentation of enzymes in a microbody, the glycosome, is essential in Trypanosoma brucei. J Cell Sci 115 (2002) 2651-2658
36. Grippa E., Gatto M.T., Leone M.G., et al. Analysis of lonidamine in rat serum and testis by high performance liquid chromatography. Biomed Chromatogr 15 (2001) 1-8
37. Newell D.R., Mansi J., Hardy J., et al. The pharmacokinetics of oral lonidamine in breast and lung cancer patients. Semin Oncol 18 (1991) 11-17